Literature DB >> 10568424

Mortality in early "sawtooth" treated rheumatoid arthritis patients during the first 8-14 years.

T Sokka1, T Möttönen, P Hannonen.   

Abstract

OBJECTIVE: To describe mortality in a cohort of early RA patients treated from the onset with disease-modifying antirheumatic drugs (DMARDs) according to the 'sawtooth' strategy. PATIENTS AND METHODS: A total of 135 early RA patients were followed up for 8-14 years or until death. Causes of death were checked on the death certificates and in patient files. Standardized mortality ratio (SMR) was calculated. Results. A total of 25 (14F, 11M) patients died during the 1422 person-years of follow-up. The SMR (95%CI) was 1.28 (0.83-1.89); 1.69 (0.92-2.82) for women and 0.98 (0.49-1.74) for men. In five cases death was closely related to RA. No one died from amyloidosis. Not a single death was caused by DMARDs in spite of extensive use of these drugs. Patient's age at the start was the only statistically significant predictor for death.
CONCLUSION: Despite active treatment with available DMARDs, RA seems still to be a fatal disease in a proportion of cases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10568424     DOI: 10.1080/03009749950155463

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  10 in total

1.  Where has secondary amyloid gone?

Authors:  B P Hazenberg; M H van Rijswijk
Journal:  Ann Rheum Dis       Date:  2000-08       Impact factor: 19.103

Review 2.  Systemic amyloidosis: a challenge for the rheumatologist.

Authors:  Federico Perfetto; Alberto Moggi-Pignone; Riccardo Livi; Alessio Tempestini; Franco Bergesio; Marco Matucci-Cerinic
Journal:  Nat Rev Rheumatol       Date:  2010-06-08       Impact factor: 20.543

Review 3.  Targeting cardiovascular risk in rheumatoid arthritis: a dual role for statins.

Authors:  Radjesh J Bisoendial; Erik S G Stroes; John J P Kastelein; Paul Peter Tak
Journal:  Nat Rev Rheumatol       Date:  2010-02-09       Impact factor: 20.543

4.  Mortality of rheumatoid arthritis in Japan: a longitudinal cohort study.

Authors:  M Hakoda; H Oiwa; F Kasagi; N Masunari; M Yamada; G Suzuki; S Fujiwara
Journal:  Ann Rheum Dis       Date:  2005-05-05       Impact factor: 19.103

5.  Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis.

Authors:  R Peltomaa; L Paimela; H Kautiainen; M Leirisalo-Repo
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

6.  Interpreting studies of cardiovascular mortality in rheumatoid arthritis: the importance of timing.

Authors:  Michael M Ward
Journal:  Arthritis Rheum       Date:  2008-12-15

7.  Causes of death in patients with rheumatoid arthritis autopsied during a 40-year period.

Authors:  R Koivuniemi; L Paimela; R Suomalainen; H Piirainen; M Karesoja; T Helve; M Leirisalo-Repo
Journal:  Rheumatol Int       Date:  2008-08-21       Impact factor: 2.631

Review 8.  Why do people with rheumatoid arthritis still die prematurely?

Authors:  S E Gabriel
Journal:  Ann Rheum Dis       Date:  2008-12       Impact factor: 19.103

9.  Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s.

Authors:  N Goodson; J Marks; M Lunt; D Symmons
Journal:  Ann Rheum Dis       Date:  2005-04-20       Impact factor: 19.103

10.  Changing trends in rheumatoid arthritis mortality in Mexico, from 1998 to 2017.

Authors:  Ivet Morales-Etchegaray; Mario Garcia-Carrasco; Pamela Munguía-Realpozo; Claudia Mendoza-Pinto; Socorro Méndez-Martínez; Olivia Navarro-Milán; Sandra Karina Velez-Pelcastre; Carlos Javier Pineda-Villaseñor
Journal:  Rheumatol Int       Date:  2021-10-05       Impact factor: 2.631

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.